Search for a report

UNITED STATES INFERTILITY TESTING & TREATMENT MARKET FORECAST 2021-2026

  • You are here:
  • Home
  • Downloads
  • UNITED STATES INFERTILITY TESTING & TREATMENT MARKET FORECAST 2021-2026

UNITED STATES INFERTILITY TESTING & TREATMENT MARKET FORECAST 2021-2026

The United States infertility testing & treatment market is forecasted to register a CAGR of 12.20% over the estimated period. The market growth of the country is facilitated by key factors including the increasing rates of infertility, the rise in middle-age pregnancies, and technological advancements in IVF procedures. The base year considered for the market study is 2020, and the forecasting period is from 2021 to 2026.

UNITED STATES INFERTILITY TESTING & TREATMENT MARKET FORECAST 2021-2026

United States Infertility Testing & Treatment Market by Gender ( Male (Male Infertility Testing ( Dna Fragmentation, Oxidative Stress Analysis, Sperm Penetration Assay, Computer-assisted Semen Analysis (Casa), Sperm Agglutination, Microscopic Examination, Others ) Male Infertility Treatment (Medication, Assisted Reproductive Technology & Varicocele Surgery)) (Female ( Female Infertility Testing ( Ovulation Testing, Hysterosalpingography, Laparoscopy, Transvaginal Ultrasound, Ovarian Reserve Testing, Hormonal Level Testing, Others) Female Infertility Treatment ( IVF With ICSI, IUI, IVF Without ICSI, Surrogacy, Others)) Market by End-user ( Fertility and Surgical Centers, Hospitals and Research Laboratories, Cryobanks)

Request free sample

The United States infertility testing & treatment market is forecasted to register a CAGR of 12.20% over the estimated period. The market growth of the country is facilitated by key factors including the increasing rates of infertility, the rise in middle-age pregnancies, and technological advancements in IVF procedures. The base year considered for the market study is 2020, and the forecasting period is from 2021 to 2026.
united-states-infertility-testing-and-treatment-market
Among developed nations, the United States’ assisted fertility and reproduction industry has the least regulations, compared to Europe as well as other regions. While insurance coverage in the United States varies significantly, IVF clinics and medical institutions are affiliated with multiple international and national health plans to recover the expenses. For instance, the Reproductive Medicine Institute (RMI), Chicago, has a contract of numerous health plans for financing treatments associated with IVF. Some of the health plans offered by the RMI for their IVF patients are ENH/gynecological surgery, Unicare PPO, BlueCross/BlueShield HMO-Illinois, CIGNA, United Health Care, and ElmCare, among others.

The coverage of infertility treatment has also been mandated across several regions in the United States. Although no specific federal laws are in place to regulate the industry’s reimbursement scenario, the IVF bills are primarily presented by governments. As a result, these factors are set to influence the United States infertility testing & treatment market growth during the forecast period.

Cook Medical Inc, headquartered in the United States, is a medical device firm that manufactures, develops, and distributes devices for minimally invasive medicine. Its main products include feeding tubes, balloons, catheters, needles, stents, wire guides, grafts, plugs, and extractors. The company distributes its products and services across diverse specialty fields, such as neurosurgery, cardiothoracic surgery, general surgery, gynecologic oncology, plastic surgery, traumatology, and others.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • COUNTRY SNAPSHOT
      • COUNTRY ANALYSIS
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
    3. KEY ANALYTICS
      • IMPACT OF COVID-19 ON INFERTILITY TESTING & TREATMENT MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • KEY BUYING CRITERIA
        • TREATMENT OPTIONS
        • QUALITY OF MEDICAL PROCEDURES
        • PRICE OF TREATMENTS
        • SHIFT TOWARDS MEDICAL TOURISM
        • REIMBURSEMENT
      • REGULATORY FRAMEWORK
      • VALUE CHAIN ANALYSIS
        • RAW MATERIAL PROCUREMENT
        • MANUFACTURING
        • SUPPLY LOGISTICS
        • DISTRIBUTION CHANNELS
        • END-USERS
    1. MARKET BY GENDER
      • MALE
        • MALE INFERTILITY TESTING
          • DNA FRAGMENTATION
          • OXIDATIVE STRESS ANALYSIS
          • SPERM PENETRATION ASSAY
          • COMPUTER-ASSISTED SEMEN ANALYSIS (CASA)
          • SPERM AGGLUTINATION
          • MICROSCOPIC EXAMINATION
          • OTHERS
        • MALE INFERTILITY TREATMENT
          • MEDICATION
          • ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY
      •  FEMALE
        • FEMALE INFERTILITY TESTING
          • OVULATION TESTING
          • HYSTEROSALPINGOGRAPHY
          • LAPAROSCOPY
          • TRANSVAGINAL ULTRASOUND
          • OVARIAN RESERVE TESTING
          • HORMONAL LEVEL TESTING
          • OTHERS
        • FEMALE INFERTILITY TREATMENT
          • IVF WITH ICSI
          • IUI
          • IVF WITHOUT ICSI
          • SURROGACY
          • OTHERS
    1. MARKET BY END-USER
      • FERTILITY AND SURGICAL CENTERS
      • HOSPITALS AND RESEARCH LABORATORIES
      • CRYOBANKS
    2. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS & AGREEMENTS
      • COMPANY PROFILES
        • COOPER SURGICAL
        • COOK MEDICAL INC
        • EMD GROUP (MERCK KGAA)
        • ESCO MEDICAL
        • FUJIFILM IRVINE SCIENTIFIC
        • VITROLIFE AB

    TABLE LIST

    TABLE 1: MARKET SNAPSHOT – UNITED STATES INFERTILITY TESTING & TREATMENT

    TABLE 2: REGULATORY FRAMEWORK

    TABLE 3: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY GENDER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 4: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY GENDER, FORECAST YEARS, 2021-2026 (IN $ MILLION)

    TABLE 5: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY MALE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 6: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY MALE, FORECAST YEARS, 2021-2026 (IN $ MILLION)

    TABLE 7: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TESTING, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 8: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TESTING, FORECAST YEARS, 2021-2026 (IN $ MILLION)

    TABLE 9: PROS AND CONS OF DNA SHARING METHODS

    TABLE 10: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 11: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, FORECAST YEARS, 2021-2026 (IN $ MILLION)

    TABLE 12: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 13: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE, FORECAST YEARS, 2021-2026 (IN $ MILLION)

    TABLE 14: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 15: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, FORECAST YEARS, 2021-2026 (IN $ MILLION)

    TABLE 16: COST OF OVULATION TESTING KITS IN THE US

    TABLE 17: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 18: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, FORECAST YEARS, 2021-2026 (IN $ MILLION)

    TABLE 19: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 20: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY END-USER, FORECAST YEARS, 2021-2026 (IN $ MILLION)

    FIGURE LIST

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VALUE CHAIN ANALYSIS

    FIGURE 5: KEY BUYING CRITERIA

    FIGURE 6: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY GENDER, IN 2020

    FIGURE 7: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY MALE, 2021-2026 (IN $ MILLION)

    FIGURE 8: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY MALE, IN 2020

    FIGURE 9: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2021-2026 (IN $ MILLION)

    FIGURE 10: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY MALE INFERTILITY TESTING, IN 2020

    FIGURE 11: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY DNA FRAGMENTATION, 2021-2026 (IN $ MILLION)

    FIGURE 12: CAUSES OF SPERM DNA FRAGMENTATION

    FIGURE 13: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY OXIDATIVE STRESS ANALYSIS, 2021-2026 (IN $ MILLION)

    FIGURE 14: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY SPERM PENETRATION ASSAY, 2021-2026 (IN $ MILLION)

    FIGURE 15: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY COMPUTER-ASSISTED SEMEN ANALYSIS (CASA), 2021-2026 (IN $ MILLION)

    FIGURE 16: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY SPERM AGGLUTINATION, 2021-2026 (IN $ MILLION)

    FIGURE 17: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY MICROSCOPIC EXAMINATION, 2021-2026 (IN $ MILLION)

    FIGURE 18: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY OTHERS, 2021-2026 (IN $ MILLION)

    FIGURE 19: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2021-2026 (IN $ MILLION)

    FIGURE 20: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY MALE INFERTILITY TESTING, IN 2020

    FIGURE 21: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY MEDICATION, 2021-2026 (IN $ MILLION)

    FIGURE 22: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY, 2021-2026 (IN $ MILLION)

    FIGURE 23: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE, 2021-2026 (IN $ MILLION)

    FIGURE 24: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY FEMALE, IN 2020

    FIGURE 25: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2021-2026 (IN $ MILLION)

    FIGURE 26: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY FEMALE INFERTILITY TESTING, IN 2020

    FIGURE 27: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY OVULATION TESTING, 2021-2026 (IN $ MILLION)

    FIGURE 28: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY HYSTEROSALPINGOGRAPHY, 2021-2026 (IN $ MILLION)

    FIGURE 29: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY LAPAROSCOPY, 2021-2026 (IN $ MILLION)

    FIGURE 30: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY TRANSVAGINAL ULTRASOUND, 2021-2026 (IN $ MILLION)

    FIGURE 31: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY OVARIAN RESERVE TESTING, 2021-2026 (IN $ MILLION)

    FIGURE 32: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY HORMONAL LEVEL TESTING, 2021-2026 (IN $ MILLION)

    FIGURE 33: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY OTHERS, 2021-2026 (IN $ MILLION)

    FIGURE 34: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2021-2026 (IN $ MILLION)

    FIGURE 35: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY FEMALE INFERTILITY TREATMENT, IN 2020

    FIGURE 36: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY IVF WITH ICSI, 2021-2026 (IN $ MILLION)

    FIGURE 37: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY IUI, 2021-2026 (IN $ MILLION)

    FIGURE 38: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY IVF WITHOUT ICSI, 2021-2026 (IN $ MILLION)

    FIGURE 39: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY SURROGACY, 2021-2026 (IN $ MILLION)

    FIGURE 40: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY OTHERS, 2021-2026 (IN $ MILLION)

    FIGURE 41: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY END-USER, IN 2020

    FIGURE 42: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY FERTILITY AND SURGICAL CENTERS, 2021-2026 (IN $ MILLION)

    FIGURE 43: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY HOSPITALS AND RESEARCH LABORATORIES, 2021-2026 (IN $ MILLION)

    FIGURE 44: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, BY CRYOBANKS, 2021-2026 (IN $ MILLION)

    1. MARKET BY GENDER
      • MALE
        • MALE INFERTILITY TESTING
          • DNA FRAGMENTATION
          • OXIDATIVE STRESS ANALYSIS
          • SPERM PENETRATION ASSAY
          • COMPUTER-ASSISTED SEMEN ANALYSIS (CASA)
          • SPERM AGGLUTINATION
          • MICROSCOPIC EXAMINATION
          • OTHERS
        • MALE INFERTILITY TREATMENT
          • MEDICATION
          • ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY
      •  FEMALE
        • FEMALE INFERTILITY TESTING
          • OVULATION TESTING
          • HYSTEROSALPINGOGRAPHY
          • LAPAROSCOPY
          • TRANSVAGINAL ULTRASOUND
          • OVARIAN RESERVE TESTING
          • HORMONAL LEVEL TESTING
          • OTHERS
        • FEMALE INFERTILITY TREATMENT
          • IVF WITH ICSI
          • IUI
          • IVF WITHOUT ICSI
          • SURROGACY
          • OTHERS
    1. MARKET BY END-USER
      • FERTILITY AND SURGICAL CENTERS
      • HOSPITALS AND RESEARCH LABORATORIES
      • CRYOBANKS

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      Add to Cart